Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Controversy

Rebuttal

CMAJ January 09, 2001 164 (1) 40;
  • Article
  • Responses
  • Metrics
  • PDF
Loading

I support universal influenza immunization because influenza is a serious public health problem. The influenza vaccine is safe and effective at preventing influenza; immunization of only high-risk populations has been largely ineffective; and we are unprepared for an influenza pandemic. I believe that it is reasonable to expect that a universal immunization program will protect vulnerable populations (e.g., children), improve coverage of high-risk populations, reduce community transmission, improve preparedness for a pandemic and perform all of this in a cost-effective manner. The Ontario program should be carefully evaluated to determine whether it achieves these objectives.

Dr. Demicheli views universal immunization from the narrow perspective of benefits for healthy adults. The real world of public health is not so simple. Dr. Demicheli ignores the potential additional benefits of protecting vulnerable populations, improving high-risk coverage, reducing community transmission and improving preparedness for a pandemic.

Dr. Demicheli agrees that the published results of studies of the cost-effectiveness of universal influenza immunization are equivocal. He makes an excellent point about “the impossibility of transferring economic evaluations from one social context to another.” In other words, conclusions from studies of cost-effectiveness conducted for British soldiers have very limited application to an Ontario public program.

Population immunization was one of the truly outstanding public health achievements of the 20th century. Immunization has proven itself, time and time again, to be safe, effective and efficient. Immunization has eradicated smallpox, eliminated polio from the western hemisphere and controlled many diseases including measles, rubella and diphtheria.

Despite this outstanding record of success, we are reluctant to exploit the full potential of immunization. We procrastinated for almost 20 years before adopting the pneumococcal vaccine, and we still do not have public health immunization programs against adolescent pertussis. Immunization is our best strategy against influenza, as even Dr. Demicheli concedes. But it won't work unless we use it.

Footnotes

  • Dr. Schabas responds to Dr. Demicheli:

PreviousNext
Back to top

In this issue

CMAJ
Vol. 164, Issue 1
9 Jan 2001
  • Table of Contents
  • Index by author
  • Canadian Adverse Drug Reaction Newsletter (91-98)

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rebuttal
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rebuttal
CMAJ Jan 2001, 164 (1) 40;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Rebuttal
CMAJ Jan 2001, 164 (1) 40;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed
  • Rebuttal
  • The analysis by Manuel and colleagues creates controversy with headlines, not data
Show more Controversy

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire